Trinity Biotech, the Dublin-based medical diagnostics group today reported a 6.9 per cent rise in revenues the company said today.
Trinity said compared to the same period last year revenues have increased by 26.8 per cent
in the third quarter to €21.4 million.
The company reported gross profits of $11 million in the period, representing a gross margin of 51.3 per cent. This compares to a gross profit of $10.3 million in the second quarter.
It said increased marketing in the US had paid off and contributed to and a 24.2 per cent rise in profits in the third quarter.
READ MORE
The company said EBITDA were $3.1m for the quarter and reported earnings per share of 2.68 cents.